Nanomedicine and Life Sciences Companies

Serendip develops solutions and processes that combine advanced technology with environmental compatibility, providing high added value for manufacturers of creams, gels, lotions and ointments in the life sciences sector.

Manufacturer of SilvaGard, a silver nanoparticle antimicrobial surface treatment for medical devices.

The basic technology platform of Activery™ is a nanoparticle production method using supercritical fluids (SCF). Based on SCF the company intends to create new medicines and modified active ingredients for pharmaceutical and cosmetic use.

Developer of ultra-miniaturized nanoarray technologies. Molecular analysis systems are capable of providing nanometer scale, single molecule resolution. Applications in proteomics, diagnostics, and therapeutics.

Deerac Fluidics is a global leader in microlitre and nanolitre liquid handling systems for the Life Sciences industry.

The company's NLP technology produces a generation of particles which retains the strength of the Dermazone Solutions' (SDMC) technologies, but includes the ability to produce particles of 60 nanometers to 150 nanometers which are optically clear. The use of this generation of lipid-based particle delivery system provides the ability to control the size of the final particle by controlling the number of NLPs used to assemble the finished particle. This system maintains very high loading capacity of passenger molecules and uses only safe, all natural ingredients to form both the NLPs and the final delivery system.

A specialized biomedical instrument designer, manufacturer, sales and consulting company.

The company's proprietary NanoCrystal® technology can enable formulation and improve compound activity and final product characteristics for poorly water-soluble compounds.

Offers different microfluidic platforms that precisely manipulate different combinations of fluids to obtain jets, emulsions, bubbles, drops and particles in the nano and micrometric range.

Primary goals of the company are the development and the establishment of innovative bioinstrumentation based on Femtosecond Laser Technology for biotechnology, cell biology and medicine, e.g. nanoprocessing with femtosecond near infrared laser pulses.

Develops and manufactures acoustic droplet ejection (ADE) systems, a fully automated, non-contact, nozzle-free technology to dispense nanoliters of liquids.

Carries out biomedical research where surface properties play a key role. Has the ability to modify the topography of bone surfaces at the nanoscale, producing a multitude of convenient attachment sites for a number of molecules, proteins and cells, which promotes bone growth.

MagnaMedics is active in the field of developing and commercializing Nano tools and systems for Life Science Research, analytical laboratories, medical diagnostics and therapies.

The MicroTransponder, Inc. technology portfolio consists of a wireless micro-system that can interface with peripheral nerves and a host of biochemical micro/nano- sensors.

Develops nanobiotechnology platforms that address global healthcare needs.

Offers a nanoencryption technology which is a layered pharmaceutical brand protection solution based on proprietary nanolithographic encryption technology.

(Site in French) A bionanotechnology firm that develops portable x-ray devices for cancer therapy.

A specialty pharmaceutical company dedicated to developing improved therapeutic and diagnostic products to treat or detect cancer and other serious diseases. The company's core technology, Nanotemplate Engineering, is a nanoparticle manufacturing technology used to formulate small molecules, peptides, proteins, plasmid DNA, and diagnostic agents.

Nanopeutics is the joint venture established by Alltracel and Elmarco to globally commercialize nanospider™ technology for the healthcare market. The patented nanospider™ technology enables the production of nanofiber materials on an industrial scale.

The company's nanofluidization process utilizes a proprietary nanotechnology process which allows molecules to be embedded into nanosuspensions (or nanodroplets) and microdroplets of between about 10 nm to about 10 µm in size, which are used to create highly solulable, stable and uniform emulsions/dispersions.

Nanoxis is a biotechnology company with extensive knowledge and experience in membrane protein research. Nanoxis has nanoscale technology solutions based on soft polymer and fluid-state liquid crystalline materials. The company is working on research and development of new nanofabrication technologies in soft polymer and fluid-state liquid crystalline material. These technologies are applicable for production of biochips used in proteomics and genetics and as advanced components for nanofluidics, nanoelectronics and robotics.

Active in the field of automating cell biology, the company's portfolio reaches from Optical Instruments and Automation Systems to Nano Liquid Handling Solutions and Cell Handling Devices.

A medical device company dedicated to reducing deaths from heart attacks The company applies nanotechnology techniques ot fabricating its stent products.

The company is developing intelligent medicine products internally and in partnership with device, pharmaceutical and biotechnology companies. These products address therapeutic areas where disease management complexity, patient monitoring requirements, therapeutic efficacy, and poor patient adherence create large clinical and commercial opportunities.

Proxeon develops state-of-the-art solutions to solve many of the scientific and technical challenges that are faced by those working in the field of proteomics. The company's core competencies are in the areas of mass spectrometry, protein analysis, hardware and software design for proteome analysis.